Abstrait
L’urosepsis regroupe les infections urinaires entraînant une réponse inflammatoire systémique. Ce terme sous-entend le plus souvent un élément de gravité. Il représente de 10 à 20 % des cas de sepsis en général, dont l’incidence annuelle est estimée à 240 cas pour 100 000 habitants. Il touche essentiellement la personne de plus de 50 ans sans prédominance de sexe.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
Références
Northeast health care quality foundation, Urosepsis. Coding and DRG notes 2003
Kunin CM (2003) Definition of acute pyelonephritis vs the urosepsis syndrome. Arch Intern Med. 163(19): 2393; author reply 2393–4
Bone RC et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6): 1644–1655
Martin GS et al. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16): 1546–1554
Brun-Buisson C et al. (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. Jama 274(12): 968–974
Brun-Buisson C, Doyon F, Carlet J (1996) Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 154(3 Pt 1): 617–624
Sands KE et al. (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. Jama 278(3): 234–240
Paradisi F, Corti G, Mangani V (1998) Urosepsis in the critical care unit. Crit Care Clin 14(2): 165–180
Alberti C et al. (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28(2): 108–121
Angus DC et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7): 1303–1310
Brun-Buisson C et al. (2004) Episepsis: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30(4): 580–588
Stamm WE, Norrby SR (2001) Urinary tract infections: disease panorama and challenges. J Infect Dis 183 Suppl 1: S1–4
Carson C, Naber KG (2004) Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Drugs 64(12): 1359–1373
Melekos MD, Naber KG (2000) Complicated urinary tract infections. Int J Antimicrob Agents 15(4): 247–256
Stamm WE (2002) Scientific and clinical challenges in the management of urinary tract infections. Am J Med 113 Suppl 1A: 1S–4S
Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348(2): 138–150
Stamm WE (2003) Urinary tract infections. Infect Dis Clin North Am 17(2): 13–14
Stamm WE (1992) Criteria for the diagnosis of urinary tract infection and for the assessment of therapeutic effectiveness. Infection. 20 Suppl 3: S151–S154 discussion S160–1
Société franÇaise d’anesthésie et de réanimation, Antibiothérapie probabiliste des états infectieux graves. in conférence de consensus (2004) Paris
Stamm WE and TM Hooton (1993) Management of urinary tract infections in adults. N Engl J Med 329(18): 1328–1334
Bernard GR (2003) Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Crit Care Med 31(1 Suppl): p. S85–S93
Rights and permissions
Copyright information
© 2007 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Revest, M., Tattevin, P. (2007). Urosepsis. In: Les infections urinaires. Monographies en urologie. Springer, Paris. https://doi.org/10.1007/978-2-287-48617-3_12
Download citation
DOI: https://doi.org/10.1007/978-2-287-48617-3_12
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-25172-6
Online ISBN: 978-2-287-48617-3